Leflunomide for the treatment of rheumatoid arthritis-Reference-Cited by-同舟云学术

Leflunomide for the treatment of rheumatoid arthritis

Published:2002-07-22 Issue:7 Volume:2010 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Osiri Manathip¹,Shea Beverley²,Welch Vivian³,Suarez-Almazor Maria E⁴,Strand Vibeke⁵,Tugwell Peter⁶,Wells George A⁷

Affiliation:

1. Faculty of Medicine; Department of Medicine; Chulalongkorn University 1873 Rama IV Road, Pathumwan Bangkok Thailand 10330

2. University of Ottawa; Institute of Population Health; 1 Stewart St. Room 312 Ottawa Ontario Canada K1N 6N5

3. University of Ottawa; Centre for Global Health, Institute of Population Health; 1 Stewart Street, Room 206 Ottawa Ontario Canada K1N 6N5

4. The University of Texas, M.D. Anderson Cancer Center; General Internal Medicine, Ambulatory Treatment and Emergency Care; 1515 Holcombe Blvd Unit 1465 Houston Texas USA 77030

5. Stanford University; Division of Immunology; 306 Ramona Road Portola Valley California USA 94028

6. Ottawa Hospital; Centre for Global Health, Institute of Population Health, Department of Medicine; 1 Stewart Street Ottawa Ontario Canada K1N 6N5

7. University of Ottawa Heart Institute; Cardiovascular Research Reference Centre; Room H1-1 40 Ruskin Street Ottawa Ontario Canada K1Y 4W7

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002047/fullpdf

Reference90 articles.

1. Amit M A comparative 2-year clinical study of combined leflunomide and methotrexate vs methotrexate alone as DMARD in rheumatoid arthritis Abstract book, the 11th APLAR meeting, Jeju, South Korea Seoul Sep 2004 93

2. A comparative 3-year clinical study of combined leflunomide and methotrexate vs methotrexate alone as DMARD in rheumatoid arthritis;Amit;The Journal of Rheumatology,2006

3. Efficacy and safety of leflunomide alone and in combination with methotrexate in the treatment of refractory rheumatoid arthritis;Antony;Indian Journal of Medical Sciences,2006

4. Treatment of rheumatoid arthritis with leflunomide: a double blind, randomised controlled study;Bao;China Journal of Rheumatology,2000

5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial;Bao;Chinese Medical Journal,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating cognitive deficits with teriflunomide: unraveling PI3K-modulated behavioral outcomes in mice;Molecular Biology Reports;2024-05-09

2. Validated chromatographic methods for determination of teriflunomide and investigation of its intrinsic stability;BMC Chemistry;2024-05-03

3. Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis;Journal of Personalized Medicine;2023-10-29

4. Drug repurposing—an emerging strategy in cancer therapeutics;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-06-13

5. 2018 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis;Rheumatology and Immunology Research;2021-03-01